A carregar...

Phase I/II Trial of Clofarabine and Cytarabine in Children With Relapsed/Refractory Acute Lymphoblastic Leukemia (AAML0523): A Report From the Children’s Oncology Group

BACKGROUND: The discovery of effective re-induction regimens for children with more than one relapse of acute lymphoblastic leukemia (ALL) remains elusive. The novel nucleoside analog clofarabine exhibits modest single agent efficacy in relapsed ALL, though optimal combinations of this agent with ot...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Cooper, Todd M., Razzouk, Bassem I., Gerbing, Robert, Alonzo, Todd A., Adlard, Kathleen, Raetz, Elizabeth, Gamis, Alan S., Perentesis, John, Whitlock, James A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4605828/
https://ncbi.nlm.nih.gov/pubmed/23335239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24398
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!